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Abstract
Normal functioning of mitochondria is crucial for cardiac performance. Mitochondria 
undergo mitophagy (mitochondrial autophagy) and biogenesis, and mitochondrial 
proteins are subject to extensive post-translational modifications (PTMs). The state of 
mitochondrial homeostasis reflects overall cellular fitness and longevity. Perturbed mito-
chondria produce less adenosine triphosphate (ATP), release greater amounts of reac-
tive molecules, and are more prone to apoptosis. Therefore mitochondrial turnover is 
an integral aspect of quality control in which dysfunctional mitochondria are selectively 
eliminated through mitophagy. Currently, the progressive deterioration of physiological 
functions is seen as accumulation of modified/damaged proteins with limiting regen-
erative ability throughout aging in myocardial cells. Mitochondrial stress response to 
reactive species was evaluated as electron transport chain (ETC) complexes, redox-active 
molecules, and their possible communication. Protein-protein interactions revealed a 
strong linkage between age and ETC protein subunits. Redox state was strongly affected 
in senescent mitochondria with shift in favor of more pro-oxidizing condition within car-
diomyocytes. Assume all together, dysfunctional proteostasis can play a causative role in 
aging and restoration of protein homeostasis machinery is protective against aging and 
possibly age-related disorders.
Keywords: aging, heart, mitochondria, protein-protein interactions, redox homeostasis
1. Introduction
The world population ages rapidly, mostly because of increasing longevity and declining 
fertility [1]. The average lifespan of the human populations is increasing worldwide and it 
is predicted that in 2035, nearly every fourth individual will be 65 years or older [2]. Aging 
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is a complex phenomenon with a large impact on society. Aging is recently an emerging 
topic since the life expectancy is rising and because aging itself is the basis for the develop-
ment of age-related diseases such as cardiovascular disease (CVD), cancer, neurodegenera-
tive diseases and degenerative metabolic diseases (e.g. diabetes mellitus type 2) [3]. Since 
age is the largest risk factor for CVD, the prevalence of these ailments increases dramati-
cally with increasing age. Over 80% of all cases of coronary artery disease and more than 
75% of those of congestive heart failure are observed in elderly patients [4]. In order to 
improve prevention and care for patients, it is important to analyze processes linked with 
cardiac aging. Prevalence of high blood pressure, obesity and metabolic syndrome corre-
late with age, and all these conditions facilitate the development of cardiomyopathies that 
are the major cause of chronic disability, morbidity and mortality in the elderly. Although 
the long-term exposure to cardiovascular risk factors plays a major role in the etiopatho-
genesis of CVD and neurodegeneration, intrinsic alterations in the heart and the vascu-
lar system occur during lifespan and render the cardiovascular system more vulnerable 
during senescence. The possible link between aging and senescence was first described 
in 1961 [5] and it based on the inability of telomeres to sustain their lengths. In addition 
to this, other events and signals were identified including non-telomeric/genotoxic stress 
generated by various signals, such as mitochondrial deterioration, oxidative stress, DNA-
replication “stress” or activated oncogenes [6]. Several lines of evidence indicate mito-
chondrial dysfunction to be a major contributor to cardiovascular senescence. Damaged 
mitochondria are bioenergetically less efficient and they are producing excessive amounts 
of reactive oxygen species (ROS) with detrimental structural and functional consequences 
[7]. The ROS impair excitation-contraction coupling, cause arrhythmias, and contribute 
to cardiac remodeling by inducing cardiac hypertrophy, apoptosis, necrosis, and fibrosis 
[8]. However, antioxidant interventions in patients with CVD yielded only disappointing 
results so far [9].
The accumulation of abnormal/dysfunctional mitochondria is usually a consequence of 
impaired clearance of damaged organelles by autophagy and inadequate replenishment of 
the cellular mitochondrial pool by mitochondriogenesis [7]. Autophagic flux is generally 
decreased in aging hearts. Murine loss-of-function models for autophagy develop exacer-
bated cardiac dysfunction that is accompanied by accumulation of misfolded proteins and 
dysfunctional organelles. On the other hand, stimulation of autophagy in mouse models 
improves cardiac function and enables to study a protein aggregation by removing accumu-
lated misfolded proteins, dysfunctional mitochondria, and damaged DNA, thereby alleviat-
ing aging-associated pathology in the heart. Multiple lines of evidence suggest that autophagy 
is required for many mechanisms that mediate lifespan extension, such as caloric restriction. 
These results are pointing out the possibility that autophagy may play an important role in 
combating the adverse effects of aging in the heart [10]. At the molecular level, the aging pro-
cess is associated with accumulation of damaged proteins and organelles, partially due to 
defects in protein quality control systems. Since most cellular functions are performed by 
proteins, aging may be, in part, the consequence of a deregulation or malfunction of the cel-
lular proteome [11]. Modern techniques enabled the investigation of the internal structure 
and morphology of mitochondria and revealed a highly complex compartmentalization [12] 
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with the challenge to dissect the communication and maintenance of the individual compart-
ments. Part of this is to ensure proteostasis (folding, unfolding and degradation) to generate 
a homeostasis of the functional proteome and to clear mistargeted/damaged proteins. It is not 
easy, because every submitochondrial compartment needs to control its redox milieu, which is 
interestingly highly different, e.g. the inner membrane separates the reducing matrix from the 
more oxidizing intermembrane space [13]. The complexity of the proteome supersedes that 
of the genome due to alternative splicing events and post-translational modifications (PTMs). 
Specific position has the mitochondrial intermembrane space (MIMS) with its role in protein 
and lipid transport, regulation and assembly of the respiratory transport system, regulation 
of redox processes, coordination of apoptosis and metal ion homeostasis [14]. One of the big 
challenges of future research will be to investigate how the mitochondrion communicates 
with the cytosol and the nucleus. The MIMS exhibits specific redox environment and con-
trolled porine-facilitated leakiness through the outer membrane allowing the free diffusion of 
small molecules (less than 5 kDa) that might harbor candidates mediating the communication 
from signaling pathways occurring inside the mitochondria toward other organelles [15].
Mitochondrial homeostasis is associated with overall cellular fitness and cellular longevity. 
Therefore, it determines also normal physiology of organ systems and performance of the 
body. Recent studies suggest that restoration of mitochondrial dynamics and mitophagy 
could delay organ senescence and prevent age-associated cardiac diseases. Here, we discuss 
the current understanding of mitochondria with particular focus on the heart, specifically the 
close relationship between mitochondrial dynamics or mitophagy suggesting a possible link 
to the regulation of redox metabolism, and intercellular protein communication.
2. Cellular senescence and mitochondria
Cells undergo widespread changes and develop specific characteristics during senescence 
that are considered as senescence markers. However, no individual marker has been so far 
identified as entirely selective parameter for cellular senescence. Nevertheless, a combination 
of several markers might be evaluated and can help to define the current stage of senescence. 
Phenotypically, the increase in size and protein content was reported in senescent cells [16, 
17] which is in agreement with our results. The data in Table 1 show that the total protein 
concentration was elevated in senescent (27 months old) rat mitochondria by 40% (p < 0.01). 
Protein concentration (mg/ml) Age (months)
6 14 27
Homogenate 20.87 ± 2.50 23.96 ± 1.46 19.19 ± 2.96
Mitochondria 5.69 ± 0.61 5.38 ± 0.49 9.56 ± 0.05**
Values are expressed as Mean ± SEM of 5 individual experiments, **p<0.01; significantly different in comparison to 6 
months old rats.
Table 1. Protein concentration in homogenate and mitochondria during aging in heart (yet unpublished data).
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However, the protein content in homogenates as well as in isolated mitochondrial fraction 
was maintained during overall aging process comparing the samples from old (14 months 
old) and adult (6 months old) rat hearts.
Further, senescent cells exhibit enlarged nuclei and lysosomes, which possess elevated senes-
cence-associated β-galactosidase activity (SA-β-Gal), the most widely used marker [17]. They 
also enter a proliferative arrest state, detected by cell cycle inhibitor levels such as p53/p21, 
tumor suppressor p16INK4a [18, 19] and markers of proliferation like Ki-67 and 5-bromodeoxy-
uridine [20]. Other factors secreted during senescence are cytokines, chemokines, growth fac-
tors, proteases, fibronectin as well as ROS and reactive nitrogen species (RNS). Additionally, 
proteostatic changes during senescence accompanied by an increase in modified proteins, 
accumulation of protein aggregates and reduced functionality of the proteasomal and 
autophagy systems [3] will be discussed in following chapters. Only two parameters cur-
rently correlate with species longevity in the right sense: the mitochondrial rate of ROS pro-
duction and the degree of fatty acid unsaturation of tissue membranes. Their basal level is in 
both cases low in long-lived animals. In addition, the best-known manipulation that extends 
longevity, dietary restriction, also decreases the rate of mitochondrial ROS production and 
oxidative damage to mtDNA [21]. The available information supports a mitochondrial free 
radical theory of aging focused on low generation of endogenous damage and low sensitivity 
of membranes to oxidation in long-lived animals.
2.1. Mitochondrion – organelle with two faces
According to mitochondrial theory of aging, mitochondria are both the main source and tar-
gets of detrimental reactions initiated in association with age-dependent deterioration of the 
cellular functions. Reactions leading to increased ROS generation, mtDNA mutations, oxida-
tion of mitochondrial proteins and lipids result in subsequent induction of apoptotic events, 
impaired oxidative phosphorylation capacity, mitochondrial dynamics, and autophagy [22]. 
In addition, mitochondrial function may be affected by subject parameters like physical activ-
ity history [23], caloric restriction [21], drugs [24] and various comorbidities including obesity 
[25], insulin resistance and hypertension [26]. The primary function of mitochondria is to 
produce adenosine triphosphate (ATP) by the process of oxidative phosphorylation. In fact, 
about 90–95% of cellular oxygen is used up in oxidative phosphorylation and 3% from that 
pool can be converted to superoxide anion radical (O
2
•−). This is a very strong argument to 
mitochondria as a main source of this oxygen radical [27]. Among the most relevant ROS 
sources in heart belong NADPH oxidases (NOX) and mitochondria [28]. Recent studies dem-
onstrate that mitochondrial ROS play a critical role in mediating the cellular effects of angio-
tensin II in the cardiovascular system [29]. Angiotensin II binds to angiotensin receptor 1, 
thereby activating NOX isoform 2 and 4 leading to increased mitochondrial ROS production 
in vascular endothelial cells as well as in cardiac myocytes [30].
Two principal scenarios can be envisioned that favor increased mitochondrial ROS-formation: 
increased formation of O
2
•− at the electron transport chain (ETC) and decreased elimination 
of O
2
•− or hydrogen peroxide (H
2
O
2
) in the mitochondrial matrix. In heart failure, the first 
scenario occurs when modifications of ETC complexes like disturbed stoichiometry and 
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PTMs hamper electron flux along the ETC to provoke excessive O
2
•− formation [31] mostly 
by NADH dehydrogenase (complex I) and Cytochrome c reductase (complex III) causing 
functional uncoupling of the respiratory chain. The extent and way of individual ETC com-
plexes inhibition is different. According to Figure 1, the decline in activity of complex I and 
cytochrome c oxidase (complex IV) was more obvious during aging when compared to the 
succinate dehydrogenase (complex II) and complex III activities. Literature data are incon-
sistent among the studies, mainly due to differences in the experimental age groups and ani-
mal models, isolation/purity of mitochondria or enzyme substrate/inhibitor used for study. 
Complex I is considered to be the most important player in the game of ROS production and/
or proton-motive cascade. Loss of its activity has been attributed to the mutations in mito-
chondrial DNA (mtDNA) in aging animals and recently was linked to the apoptotic cell death 
pathway [32].
Reduced complex I activity was seen in the rat heart [33], brain synaptic mitochondria [34] 
as well as continual decrease in the frontal cortex of Parkinson disease patients [35]. It is 
important to note that the activity and stability of this respiratory complex are determined by 
its abundance, PTMs and/or specific protein–protein interactions. In contrary, other studies 
have reported no age-related decrease in complex I activity [36]. Most of the inconsistencies 
are related to the complexes II, III and IV, where activities of respiratory complexes have 
been also shown to decline [37], remain unchanged or increased during aging [38]. Our data 
show age-dependent decrease in all ETC enzyme activities, although the extent of inhibi-
tion is different (Figure 1). Among them, complex IV was most affected throughout aging 
and reached 63.4% of adult respiring mitochondria. While complexes I, II and III maintained 
activities in 14 months old rat mitochondria, cytochrome c oxidase showed deprivation by 
Figure 1. Activities of ETC complexes in heart mitochondria during aging (yet unpublished data). Values are expressed 
as Mean ± SEM of 5 individual experiments, **p < 0.01, ***p < 0.001; significantly different in comparison to 6 months old 
rats.
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21.6% (p < 0.01) when compared to the adults. Unique role in both, Krebs cycle and ETC, has 
in inner mitochondrial membrane (IMM) embedded complex II. Its function is cardiolipin-
independent and is not taking part in respiratory supercomplexes but has been identified as 
an isolated entity in mildly solubilized mitochondrial membranes [39]. This confirms the least 
damage by 13.6% in senescent mitochondria when compared to the other respiratory com-
plexes. Interestingly, recent works described the direct connection of the O
2
•− formation and 
respiratory chain complex II [40] when lack of succinate was present. At saturated succinate 
concentration and high membrane potential complex II is tightly bound with reverse transfer 
of electrons to O
2
•− -producing complex I [41].
Several factors have impact on ETC with specific role of mtDNA. ETC complexes are composed 
of both nuclear DNA-encoded (more than 80 proteins subunits) and 13 mtDNA-encoded sub-
units proteins. Respiratory chain and F
1
F
0
-ATPase deficits are adverse effects on a variety of 
cellular and tissue functions, causing a wide range of complex clinical phenotypes. The inci-
dence of inherited mitochondrial diseases is estimated to be about 1 in 5000 but a much larger 
population may be affected when somatic genetic defects, such as mtDNA mutation and dele-
tions accompanying normal aging, are considered. The frequency of the common 4977-bp 
mtDNA deletion, a typical consequence of oxidative stress [42], increases with age in the 
human heart and is estimated to be 5- to 15-fold higher in people over 40 years of age relative 
to younger individuals [43]. This deletion affects genes encoding 7 polypeptide components 
of the mitochondrial ETC. Bioenergetic consequences of 4977-bp deletions will be reflected 
when the proportion of deleted mtDNA exceeds 50–55% of total mtDNA. The involvement 
of mtDNA mutations in cardiac aging is supported by findings in mice that express a proof 
reading deficient version of mtDNA polymerase (PolG) [44]. A high load of mtDNA muta-
tions and deletions accumulate in the heart of these mice, in conjunction with the early onset 
of several age-associated changes including cardiac enlargement, fibrosis, impairment of sys-
tolic and diastolic function [30], and reduced activity of ETC complexes [44].
To maintain proton-motive force and electron transfer through ETC, reduced equivalents are 
required. In mitochondria, the Krebs cycle generates NADH, which delivers electrons to the 
ETC inducing translocation of protons across the inner mitochondrial membrane. This estab-
lishes a membrane potential that fuels the F
1
F
0
-ATPase to generate ATP. At the ETC, electrons 
can leak to produce O
2
• which is dismutated to H
2
O
2
 by Mn-dependent superoxide dismutase 
(Mn-SOD) and, in turn, is detoxified by enzymes that require NADPH. Accordingly, equilib-
rium exists between reduced and oxidized forms of equivalents NADH/NAD+ and NADPH/
NADP+ [45].
In experiments, citrate synthase is frequently used as basal mitochondrial activity marker 
to avoid possible effects of different yield of mitochondria. Increase in its activity shown in 
Figure 2 led to more pronounced activity changes in ETC complexes with age. Starting from 
citrate synthase, some of the Krebs cycle enzymes play inevitable role in reduced equivalents 
machinery, such as NAD(P)+-isocitrate dehydrogenase (ICDH) and α-ketoglutarate dehydro-
genase (KGDH). Both of the enzymes share some common features as NADH production and 
they are regulated by calcium (Ca2+). Calcium uptake dynamically controls the redox state of 
NAD(P)H in working cardiac myocytes [28] and availability of NADPH together with reduced 
glutathione is required for H
2
O
2
 removal by glutathione peroxidase/glutathione reductase 
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cycling. Therefore regeneration of NADPH is very important and depends on Krebs cycle 
enzymes, especially ICDH [46]. Interestingly, the activity of ICDH was affected only in senes-
cent mitochondria but by a significant 42.5% decrease (from 246.52 ± 1.90 to 144.04 ± 5.58) μmol/
min/mg protein. Almost equivalent to ICDH activity in senescent hearts was drop in KGDH 
activity but this enzyme has shown gradual decline during whole aging process (Figure 2). 
In heart failure, elevated intracellular Na+ promotes ROS-formation by reducing mitochon-
drial Ca2+ uptake. Therefore, mitochondrial Ca2+ uptake critically regulates mitochondrial ROS 
production/removal [28] in cooperation with Krebs cycle enzymes and other ions to main-
tain mitochondrial homeostasis. Activation of ion channels in the IMM such as mitochondrial 
permeability transition pore (MPTP), the inner membrane anion channel (IMAC) and ATP-
dependent K+-channel causes depolarization of IMM. This is accompanied by an increase in 
electron flux required to maintain ATP production. Opening of these channels might promote 
ROS production, but interestingly they can be activated by ROS themselves. Moreover, O
2
•− 
can be released from mitochondria via MPTP and IMAC. ROS in such a situation trigger oscil-
lations of membrane potential leading to higher incidence of arrhythmias during reperfusion 
in the heart [47]. It seems that oxidative stress is one of the key events in myocardial senescence 
progression and development; however, during evolution cells were equipped with antioxi-
dant defense mechanisms that can prevent/recover cells from an oxidative to a reductive state.
3. Redox homeostasis in mitochondria
Mitochondria play important role in generation of ROS and RNS but they are themselves 
players in different signaling pathways, in which the mitochondrial oxidative defense system 
Figure 2. Activities of Krebs cycle enzymes in heart mitochondria during aging (yet unpublished data). Values are 
expressed as Mean ± SEM of 5 individual experiments, **p < 0.01, ***p < 0.001; significantly different in comparison to 
6 months old rats.
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contributes to maintain redox homeostasis. Cellular redox state is determined by the reduc-
tion potentials and reducing capacities of the redox couples, such as GSH/GSSG, NAD(P)
H/NAD(P)+, thioredoxin (reduced/oxidized), glutaredoxin (reduced/oxidized) and cysteine/
cystine, From these the GSH/GSSG system is considered to be the most abundant among 
endogenous antioxidants with 2 to 4-fold higher abundance than other redox systems.
3.1. Thiol–disulfide redox state of mitochondria
Reduced form of GSH (γ-L-glutamyl-L-cysteinyl glycine) is two electron donating molecule 
and in humans is almost uniquely present in a quite high concentration (1–10 mmol/L). 
This allows GSH to scavenge ROS either directly or indirectly. As an antioxidant, it reacts 
with reactive forms and radicals produced in association with electron transport, xenobiotic 
metabolism and inflammatory responses [48]. GSH homeostasis is not only regulated by its 
de novo synthesis, but also by other factors such as utilization, recycling and cellular export. 
Cooperation with other antioxidant, redox-related enzymes is important for recycling and 
maintenance of the optimal redox environment. It was reported that GSH level decreases 
over time in heart mitochondria [49] and several brain regions [50]. This phenomenon was 
confirmed by GSH measurement in three age groups (Table 2). Rapid decline of GSH level 
was accompanied by increase in oxidized GSSG form in senescent rat hearts. Interestingly, 
14 months old hearts were able to maintain basal concentrations of that present in adult 
ones. The relative GSH/GSSG ratio indicates a decrease in GSH levels leading to more oxi-
dized environment in senescent cardiomyocytes and experimentally dilated cardiomyopathy 
in mice [51]. The total content of thiol-containing compounds (R-SH), in contrary to GSH, 
decreases very slowly (by 19.2% in senescent) during aging process.
(μmol/g of tissue) Age (months)
6 14 27
R-SH content 8.66 ± 0.46 7.12 ± 0.26 7.00 ± 0.09*
GSH content 3.00 ± 0.25 3.74 ± 0.39 1.68 ± 0.19**
GSSG content 1.77 ± 0.21 1.61 ± 0.25 3.81 ± 0.31**
GSH/GSSG ratio 1.64 2.10 0.51
Enzyme activity (μmol/min/mg protein)
GPx activity 9.033 ± 0.860 8.239 ± 0.081*** 6.489 ± 0.112***
GR activity 4.790 ± 0.093 4.194 ± 0.306** 3.960 ± 0.124***
TrxR activity 0.085 ± 0.018 0.050 ± 0.008** 0.052 ± 0.013**
Values are expressed as means ± SEM of 5 individual experiments. *p < 0.05, **p < 0.01, ***p < 0.001; significantly different 
in comparison to 6 months old rats.
Table 2. The content and activities of GSH cycle-related molecules in heart during aging (yet unpublished data).
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Aerobic respiration may result in an increase of H
2
O
2
, which is metabolized by glutathione 
peroxidase (GPx), while GSH is recycled by the action of glutathione reductase (GR). Since 
both of the enzymes were affected in old as well as senescent rat hearts, overproduction of 
H
2
O
2
 or lack of reduced NADPH was present. Moreover, peroxidase-mediated elimination 
of H
2
O
2
 will also augment the level of GSSG. This in turn, may not only lower the gluta-
thione redox potential, but also increase in amount of protein mixed disulfides. Addition 
of GSH to protein cysteine residues results to post-translational modification known as 
S-glutathionylation. It is a reversible process with potential to activate or inactivate protein 
function by modulating different cellular pathways. It is able to influence gene expression 
by affecting  different transcription factors such as Nrf2 (nuclear factor erythroid 2-related 
factor 2) or NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) [52]. 
The Nrf2-Keap1 (Kelch-like ECH-associated protein 1) pathway is the major regulator 
of cytoprotective responses to oxidative and electrophilic stress. In the presence of ROS, 
critical cysteine residues in Keap1 become oxidized leading to a conformational change, 
which prevents its binding to Nrf2. As a consequence, Nrf2 degradation is stopped and its 
nuclear translocation promoted [53]. Recently was shown that S-glutathionylation of endo-
thelial NO synthase (eNOS) at Cys689 and Cys908 leads to eNOS uncoupling, diminished NO 
production and enhanced oxidative stress linked with superoxide overproduction [54]. 
S-glutathionylation as well as GSH alone interacts with earlier mentioned nuclear factor 
Nrf2. This factor is key transcription factor of 4-hydroxy-2-nonenal (HNE). HNE is highly 
reactive aldehyde product of lipid peroxidation with potential to modulate function of 
proteins and lipids. The Nrf2 under stress conditions activates HNE-mediated antioxidant 
protection, when at a sub-lethal concentration 5 μmol/l HNE stimulates biosynthesis of 
GSH in cardiomyocytes. In contrary, glutathione after oxidation to the glutathione radi-
cal (GS•) has deleterious effects. It is able to take H+ from lipid side chains and polyun-
saturated fatty acids or to induce lipid peroxidation [55]. Altogether, S-glutathionylation 
may be a double-edged sword in the sense that it promotes antioxidant or pro-oxidant 
responses.
Peroxidase activity is found in GPx and in the thiol-specific proteins called peroxiredox-
ins (Prx). They react with H
2
O
2
 at a very high rate and their activity depends on cysteine 
residue in the active site. Peroxiredoxins can also reduce and detoxify peroxynitrite anion 
and a wide range of organic hydroperoxides. The highest reaction rate and abundance 
has Prx2 which traps almost all H
2
O
2
 in vivo [56]. The level of this powerful thiol-specific 
protein was maintained until the age of 14 months, but senescent mitochondria lost 35.1% 
of Prx2 amount (Figure 3). Oxidized cysteine residues of Prx are specifically reduced by 
Trx. Oxidized Trx as well as other oxidized cellular proteins can be reversibly reduced by 
TrxR in a NADPH-dependent manner. The Trx/TrxR system appears to have a protective 
function against oxidative stress, e.g. supports the activity of ribonucleotide reductase and 
inhibits apoptosis signal-regulated kinase-1 [57]. Thioredoxin reductase has been severely 
affected during aging process by 41.9% in group of 14 months old hearts with an extension 
until the age of 27 months (Table 2). The same scenario was observed in Trx protein level 
where the amount of protein has decreased to 62.4% in 14 months old as well as 27 months 
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old rat hearts (Figure 3). Low Trx level is probably result of TrxR malfunctioning due to 
lack of NADPH, overproduction of ROS and/or RNS. Thioredoxin also plays a role in the 
reversible S-nitrosylation of cysteine residues in target proteins, and thereby contributes to 
the response of intracellular nitric oxide (NO). In addition, Trx is able to block caspase-3 
activity through nitrosylation of the active cysteine site in response to NO. Therefore, Trx 
protein deficiency may contribute to the stimulation of caspase-dependent apoptosis. The 
most studied enzyme in the process of protein S-glutathionylation is glutaredoxin (Grx). 
The high specificity of Grx to S-glutathionylated proteins is used as a tool for studying and 
identifying them. In general, it is stated that the main task of Grx is to remove GSH from 
S-glutathionylated proteins. Thus, reduced thiol-containing protein is restored, which was 
confirmed in experiments with siRNA (small interfering RNA). The suppression of Grx 
genes with siRNA is an approach to study not only the “antioxidant” properties of Grx but 
also the role of protein S-glutathionylation [58]. Grx2 catalyzes S-glutathionylation of IMM 
proteins in a relatively reduced GSH/GSSG ratio equal to 6. The fact that thiol-disulfide oxi-
doreductases can catalyze both oxidizing and reducing reactions is not exclusive to Grx. 
Thioredoxin can act as an oxidant in oxidizing environment. Currently, the biggest challenge 
of researchers is to identify which enzymes are responsible for (de)glutathionylation, and if 
it is spontaneous process or catalyzed by enzymes. Existing information suggests that the 
Figure 3. Scheme of (A) Thiol-disulfide network and (B) protein level for Prx2, Trx (yet unpublished data). GSH-reduced 
glutathione, GSSG-oxidized glutathione, GPx-Glutathione peroxidase, GR-Glutathione reductase, Grx-Glutaredoxin, 
Prx-Peroxiredoxin, Trx-Thioredoxin, TrxR-Thioredoxin reductase, SH-reduced and SS-oxidized form of Protein, ICDH-
isocitrate dehydrogenase.
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mechanisms involved in resistance to various types of stress together with maintenance of 
bioenergetic capacity and redox homeostasis may be critical in the evolution of longevity.
3.2. Mitochondrial protein-protein network
One of the major goals of gerontology is to understand the comprehensive mechanisms 
involved in aging at different levels and hopefully to help understand age-related diseases. 
The complexity of the proteome supersedes that of the genome, due to alternative splicing 
events and PTMs of proteins. Proteomes are expected to be two to three orders of magnitude 
more complex than would be predicted from numbers of protein-encoding genes present in 
the respective genomes [59]. It is widely recognized that cellular aging causes changes in the 
proteome. However, the nature and targets of these changes and their consequences have not 
yet been completely identified. In recent years, mass spectrometry (MS) has been recognized 
as a golden standard tool for the identification and analysis of individual proteins. For further 
understanding of the molecular changes during heart aging, we have identified several pro-
teins and compared the differences in the mitochondrial protein expression profiles among 
two age groups.
Precipitated proteins from mitochondria of 6 and 27 months old rat hearts were sepa-
rated with two-dimensional electrophoresis (2-DE) to provide a protein profile (Figure 4). 
Interestingly, the change in protein level was statistically significant (1.5-fold change, 95% 
confidence interval) in only 12 proteins (marked with red circles) from the total protein 
pool of mitochondria. All the proteins were down-regulated in senescent mitochondria 
in comparison to the adult ones. Despite the small number of quantitatively modified 
proteins, these create an interesting protein-protein network. The strength of data sup-
port represents line thickness of protein-protein interaction network generated by String 
Figure 4. Representative 2-DE analysis of mitochondrial proteins in aging rat heart (yet unpublished data).
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 software and using gene IDs (Figure 5). Two proteins, methylmalonate-semialdehyde dehy-
drogenase [acylating] (Gene ID: Aldh6a1) and carnitine O-palmitoyltransferase 2 (Cpt2) 
did not fit to the protein-protein interaction map. However, their role in fatty acid metabo-
lism is very important in connection to the heart muscle work and energy production. 
The rest of the proteins participate in various metabolic pathways of mitochondria. Three 
take part in Krebs cycle – malate dehydrogenase (Mdh1), dihydrolipoyl dehydrogenase 
(Dld) and aconitate hydratase (Aco2). Post-translational cysteine-related modification of 
aconitase was reported to be a key in linkage between Krebs cycle, redox signaling and 
metabolism of ROS [60]. Next five  down-regulated proteins were directly connected with 
cardiac muscle contraction and the risk of developing age-related neuronal disorders - 
Huntington, Parkinson and Alzheimer disease. All of them are subunits of ETC, thus regu-
late production of energy in mitochondria: NADH dehydrogenase 1 alpha subcomplex 
subunit 5 (Ndufa5), cytochrome bc1 complex subunit 1 (Uqcrc1) and cytochrome bc1 com-
plex subunit Rieske (Uqcrsf2), cytochrome c oxidase subunit 5B (Cox5b), electron transfer 
flavoprotein subunit beta (Etfb). Combined defects in oxidative phosphorylation and fatty 
acid beta oxidation were detected in mitochondrial diseases [61]. Creatine kinase M-type 
(Ckm) was only one cytoplasmic enzyme interacting with mitochondria through transfer of 
phosphate and the last one is voltage-dependent anion-selective channel protein 1 (Vdac1), 
Figure 5. Functional protein-protein interactions during aging in rat mitochondria (yet unpublished data).
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which plays a role in outer mitochondrial membrane permeabilization and cellular death. 
This outer mitochondrial membrane protein is tightly bound with Alzheimer disease, 
where mediates amyloid β toxicity and represents a potential target for Alzheimer disease 
therapy [62].
Currently available evidence indicates that the steady-state amounts of structural damage 
to proteins accumulated during life are relatively small, and are often present only in trace 
amounts. On the other hand, the pro-oxidizing changes in the redox state reflected by the 
decline in redox potential, increases in production of H
2
O
2
 and level of protein modifica-
tions are significant and ubiquitous. However, the oxidative PTMs are relevant only if these 
are connected to functional consequences. It is important to consider that a slight modifica-
tion in low abundance proteins may be of physiological importance. Distinguishing between 
inconsequential modifications and functionally significant ones requires careful biochemical/
biophysical analysis of target proteins [63]. Thus, proteomic approaches represent powerful 
tools to address these questions by identifying the targeted proteins and the extent of their 
modifications.
3.3. Post-translational modifications of proteins during aging
The detailed examination of enzyme molecules by mass spectrometry and other techniques 
continues to identify hundreds of distinct PTMs. Global analyses of enzymes using pro-
teomics revealed widespread distribution of PTMs on many key enzymes located in all 
cellular compartments. Multiple PTMs within a single enzyme molecule and their mutual 
interplays are critical for the regulation of catalytic activity. Enzymatic PTMs can be detected 
in ever increasing amounts and they appear to be critical for folding and assembly (e.g. gly-
cosylation), function as key regulators of catalytic activity of enzymes (e.g. binding of pros-
thetic groups, phosphorylation), or mark enzyme molecules for targeted destruction (e.g. 
ubiquitylation). In parallel with these processes there are non-enzymatic PTMs caused by 
ROS and RNS continuously interacting with individual enzyme molecules. These PTMs 
contribute to molecular aging and may also be involved in regulation of enzymes’ cata-
lytic activity [64]. There are two groups of PTMs observed during oxidative stress mediated 
aging, reversible and irreversible. The major types of irreversible PTMs are carbonylation and 
3-nitrotyrosilation.
• Carbonylation is covalent adduction of lipid aldehyde to the side chains of lysine, histidine 
or cysteine residues. Extensive amount of information about this modification can be found 
in the recently published book [65].
• 3-nitrotyrosilation, frequently called tyrosine nitration is formed between RNS (peroxyni-
trite anion) and a tyrosine residue of target protein. Extensive research was done during 
last years in failing human [66] and rat hearts [67].
Second group of reversible PTMs which are related to the aging process are sulfur-mediated 
S-Sulfenylation, S-nitrosylation, S-glutathionylation and lipid peroxidation pathway-related 
HNE modification.
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• Protein S-Sulfenylation leads to the production of sulfur-hydroxylation product (P-SOH), 
disulfide bond and sulfenyl-amide bond formation. It may be a precursor to the process 
of S-sulfinylation and S-sulfonylation. This type of modification is believed to be a fleeting 
molecular switch that regulates non-enzymatic oxidative folding [68].
• S-nitrosylation occurs when NO is covalently incorporated into the Cysteine thiol group 
forming S-nitrosothiol (SNO). It plays important role in redox metabolism through GSH 
interaction in failing heart in rats [67] and human heart disease [69]. This PTM has been 
progressively implicated in virtually every NO-regulated process within the cardiovascu-
lar system. The current, widely-held paradigm is that S-nitrosylation plays an equivalent 
role as phosphorylation, providing a stable and controllable PTM [70].
• S-glutathionylation is covalent attachment of GSH to protein thiol groups. The function of 
protein S-glutathionylation reactions in metabolism is a rapid and reversible redox signal-
ing mechanism that involves the conjugation and removal of glutathione from cysteine 
switches. Several observations have shown that unlike other redox modifications S-gluta-
thionylation reactions fulfill the requisite criteria to serve as an effective PTM that controls 
protein function, links energy metabolism to redox signaling in mitochondria. Because of 
its role in modulation of ROS production in myocardial mitochondria, currently the usage 
of mitochondria penetrating antioxidants is discussed in context of the heart disease treat-
ment [71].
• During last decade HNE modification was under extensive research because of its dual role 
as pro- and anti-oxidant. This most abundant reactive aldehyde attacks predominantly ni-
trogen of histidine, lysine (less commonly arginine) or cysteine, and it is related to wide 
range of metabolic diseases [72].
Above mentioned PTMs occur the most frequently during oxidative stress-related aging pro-
cess. However, there are virtually hundreds of additional PTMs that may occur in enzymes. 
To support results from protein profiling of mitochondria is important to focus on deep pro-
tein analyzes of individual selected proteins, their interactions within the individual com-
partments, between different organelles or the intercellular communication. For this purpose, 
proteomics is now integrated with molecular genetics, transcriptomics, and other areas lead-
ing to systems biology strategies.
3.4. Turnover of mitochondrial proteins - role of mitophagy in cardiomyocytes
Proper functioning of mitochondria is crucial for cardiac function. Damaged mitochondria 
produce less ATP, release greater amounts of ROS, and have a lower threshold for cyto-
chrome c release resulting in apoptosis, undergo mitochondrial permeability transition 
pore opening resulting in necrosis or may release mitochondrial components into cytosol 
where are recognized by receptors for removal. Mitochondrial turnover is therefore an inte-
gral aspect of quality control in which dysfunctional mitochondria are selectively elimi-
nated through autophagy or mitochondrial autophagy (mitophagy) and replaced through 
expansion of preexisting mitochondria (biogenesis). In the heart mitochondria turnover is 
with a half life of 14 days. Rat cardiomyocytes have roughly 1000 mitochondria per cell, 
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suggesting that under basal resting conditions, one mitochondrion per cell is replaced every 
40 minutes [73]. In order to facilitate and initiate mitophagy, mitochondrial fusion and fis-
sion play a critical role in mitochondrial turnover. Fission of mitochondria into smaller 
fragments is a crucial requirement for mitophagy to occur. The key regulator of this pro-
cess is dynamin-related protein 1 (Drp1), which in concert with proteins fission 1 (Fis1), 
mitochondrial fission factor (Mff), mitochondrial dynamics proteins of 49 kDa (MiD49) 
and 51 kDa (MiD51) is responsible for mitochondrial fragmentation. The role of last three 
proteins appears essential. Mff assists in the assembly of Drp1. MiD49 and MiD51 may 
play a regulatory role by recruiting Drp1 and maintaining it in inactive state until fission is 
required [74]. Proteins that promote outer mitochondrial membrane (OMM) fusion such as 
Mitofusin 1 and 2 (Mfn1 and 2) are ubiquitinated and eliminated by the ubiquitin protea-
some system. E3 ubiquitin ligase Parkin (also known as Park2) and PTEN-induced putative 
kinase 1 (PINK1) have been shown to play an important role in mitophagy. PINK1 targets 
to the mitochondria but is normally degraded by presenilin associated rhomboid-like pro-
tease (PARL). In response to loss of mitochondrial membrane potential, PARL is inactivated; 
PINK1 is stabilized and recruits Parkin. Parkin ubiquitinates several mitochondrial associ-
ated proteins and they are then recognized by p62 and bring mitochondria to the autopha-
gosomes. Thus mitochondria with membrane potential loss can be selectively degraded. 
Parkin substrates include e.g. voltage-dependent anion-selective channel protein (VDAC), 
translocase of the outer membrane (TOM), mitochondrial fission 1 (FIS1), hexokinase, mito-
chondrial Rho-GTPase (MIRO) 1 and 2, although whether ubiquitination of these proteins is 
required or sufficient for mitophagy is unclear and highly dependent on the specific cellular 
context [75].
The importance of mitophagy for the preservation of cardiovascular homeostasis, the car-
diomyocyte-specific deletion of Parkin and the expression of a mutant Mfn2 (mitofusin 2) at 
birth prevented the switch from fetal to adult mitochondria in the mice heart [76]. Another 
example, mice bearing a heart-specific deletion of Mfn2 prematurely succumbed to a progres-
sive cardiomyopathy characterized by impaired contractile function [77]. Such a detrimental 
phenotype could be reversed, at least partially by Mfn2 to prevent the targeted mitochondria 
from rejoining the mitochondrial network through fusion. Under basal conditions Mfn2 func-
tions in mitochondrial fusion events and links endoplasmic reticulum to mitochondria. Also 
acts as Parkin receptor during mitophagy following phosphorylation by PINK1 and recruit-
ing Parkin to the mitochondria. So even in case of Parkin-dependent mitophagy, some outer 
mitochondrial membrane proteins are recycled through transfer to the endoplasmic reticu-
lum. Most studies have relied on the systemic modulation of autophagy with nutritional or 
pharmacological interventions or the homozygous/heterozygous deletion of a relevant gene. 
Nutritional and pharmacological interventions commonly used to modulate autophagy in 
the cardiovascular system in vivo, including caloric restriction or caloric restriction mimet-
ics, rapamycin, 3-methyladenine, and lysosomal inhibitors, are rather nonspecific. Genetic 
interventions offer increased specificity, but are not devoid of potential problems that should 
be kept under attentive consideration. Linking mitophagy with cardiomyocytes is the field 
of interest in many publications [78]. While mitophagy is responsible for bulk degradation 
of mitochondria, turnover of individual components may proceed at asynchronous rates 
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through redistribution of components via fusion events, selective degradation of proteins by 
mitochondrial proteases, and proteasomal elimination of some outer mitochondrial mem-
brane proteins. Some studies suggest that inner mitochondrial membrane proteins, especially 
oxidative phosphorylation constituents, may be primarily cleared via mitophagy. There is 
more to discuss, especially communication between intracellular organelles (mitochondria 
and endoplasmic reticulum) and oxidative phosphorylation events in mitochondria in rela-
tion to redox network, apoptosis/necrosis or mitophagy. These appear to be key players in 
cardiomyocytes survival during aging.
4. Conclusions
Maintenance of mitochondrial function and energy/redox homeostasis requires both genera-
tion of newly synthesized and elimination of dysfunctional mitochondria. Taken together, 
age-dependent decline of mitophagy inhibits removal of dysfunctional or redundant mito-
chondria as well as impairs mitochondrial biogenesis. It results to progressive mitochondrial 
accretion and consequently, deterioration of cardiomyocytes function. At present it is pointed 
out that the steady-state amounts of structural damage accumulated during life are rela-
tively small. However, changes in the redox state reflected by the decline in redox potential, 
increases in production of H
2
O
2
 and level of protein modifications are significant and ubiqui-
tous. Activities of ETC complexes revealed that the most affected throughout aging was com-
plex IV, in contrast to relatively small age-related changes in complex II. These non-uniform 
changes in ETC enzyme complexes may lead to altered electron transfer through the chain, 
leading to impairment of ATP synthesis and overall functionality of cardiomyocytes during 
aging. The ability of the main regulatory Krebs cycle enzymes to supplement NADH to ETC 
was altered in senescent mitochondria. ICDH and KGDH had only half activity in senescent 
mitochondria; however ICDH was not affected in group of 14 months old. This might sup-
port promotion of H
2
O
2
 in senescent cardiac myocytes where peroxiredoxin 2 ability to trap 
H
2
O
2
 was also significantly affected. Decrease in GSH levels indicates low GSH/GSSG ratio 
leading to more oxidized environment in senescent cardiomyocytes but 14-month old hearts 
were able to maintain basal levels of adult mitochondria. Despite the variations in enzyme 
activities, the overall proteomic analyses revealed only 12 significantly affected proteins dur-
ing aging. All these were more or less deprived but question is what is responsible for such 
a changes. Are these proteins really relevant? Is change in protein amount important? These 
and other questions are waiting for us and other researchers to be answered.
Specific marker of senescence was yet not identified, but evaluating a series of markers can 
help to define the senescent state. Senescent cells have greater proportion of protein content, 
which might be modulated by several PTMs. If these protein modifications are connected to 
functional consequences and protein-protein interactions are revealed, link may lead to the 
solution. Unfortunately, the proteome is much more complicated than the genome. To fit all 
the proteins together with their different characteristics in various pathways and cellular com-
partments is almost infeasible. At present, various nutritional, pharmacological and genetic 
interventions have higher or lower specificity, but are not devoid of potential  problems that 
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should be kept under attentive consideration. Collectively, these studies suggest that dys-
functional proteostasis has a causative role in aging and that restoration of protein homeo-
stasis is protective against age-related diseases. New window is opened and hopefully with 
help of bioinformatics collecting huge amounts of data from proteomics, genomics and other 
scientific approaches will lead to personalized therapeutic procedures for individual patient 
and age-related disorder(s).
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